Metformin is first-line for PCOS insulin resistance — but a fair trial takes 3 to 6 months, not weeks. Here’s how to restart with ER, track progress beyond the scale, and know when to talk with your doctor about adding a GLP-1.
Your GLP-1 choice may affect your heart as much as your weight loss. Here’s what the SELECT, SUMMIT, and LEADER trials reveal about GLP-1 heart health — and what to ask your doctor.
Peptide regulation is changing — but the FDA’s 2026 vote isn’t a green light. Here’s what’s safe, what’s not, and how to shop smart for peptide products.
You’re doing everything right with your GLP-1 medication but the scale won’t budge. This is what GLP-1 resistance means for women with PCOS, why inflammation and dose matter, and questions to ask your doctor.
Compounded GLP-1 drugs are often prescribed online without FDA approval — the Yale secret shopper study reveals a dangerous safety gap. Learn 5 questions to ask before accepting a prescription.
Ozempic feet is the latest GLP-1 side effect causing foot pain, shoe size changes, and skin issues. Learn what causes it and how to protect your feet with protein, strength training, and proper footwear.
Looking for GLP-1 alternatives? From FDA-approved pills like phentermine and Qsymia to new drugs in development targeting amylin, MC4R, and other pathways — here’s what you need to know now and what’s coming next.
New BMJ research finds weight loss drugs help drop pounds but don’t improve quality of life. Only semaglutide protects the heart. What the trade-offs mean for you.
A Yale secret shopper study reveals most GLP-1 telehealth sites prescribe with little oversight. Learn 5 red flags and 5 questions to ask before signing up.
Are you tired of endless dieting that doesn’t work? Frustrated with stubborn fat that won’t budge…
